Valuation: Femasys Inc.

Market Cap 13.99M 12.45M 11.53M 10.45M 19.64M 1.32B 19.92M 138M 54.19M 694M 52.46M 51.37M 2.21B P/E 2026 *
-0.63x
P/E 2027 * -0.94x
Enterprise Value 13.99M 12.45M 11.53M 10.45M 19.64M 1.32B 19.92M 138M 54.19M 694M 52.46M 51.37M 2.21B EV / Sales 2026 *
6.71x
EV / Sales 2027 * 1.57x
Free-Float
96.01%
Yield 2026 *
-
Yield 2027 * -
1 day-1.20%
1 week-6.25%
Current month-23.61%
1 month-36.29%
3 months-49.54%
6 months-80.56%
Current year-85.68%
1 week 1.46
Extreme 1.46
1.81
1 month 1.46
Extreme 1.46
2.69
Current year 1.46
Extreme 1.46
14.51
1 year 1.46
Extreme 1.46
22.2
3 years 1.46
Extreme 1.46
48
5 years 1.46
Extreme 1.46
162
10 years 1.46
Extreme 1.46
275
Manager TitleAgeSince
Chief Executive Officer 58 2003-12-31
Director of Finance/CFO 58 2022-02-27
Chief Operating Officer 52 2026-03-29
Director TitleAgeSince
Chairman 74 2022-07-05
Chairman 58 2003-12-31
Director/Board Member 75 2005-07-31
Date Insider Type Main position Quantity % Market Cap. Importance
8/7/26 Buy

Chief Technology Officer

9,375 0.1166%
8/7/26 Buy

Chief Financial Officer

46,875 0.5832%
8/7/26 Buy

Founder

46,875 0.5832%
Change 5-day change 1-year change 3-year change Capi.($)
-1.20%-6.25%-86.28%-93.12% 13.99M
-1.89%-2.05%-22.39%+3.85% 177B
-2.23%+5.33%-21.93%+12.01% 117B
-1.69%+0.02%-3.01%+27.96% 116B
+15.48%+18.80%-44.63%+6.59% 77.71B
-0.83%+3.13%+3.98%+80.36% 65.51B
+1.98%+4.70%+17.36%+81.35% 54.97B
+0.28%+3.72%+1.75%-24.86% 52.79B
-0.80%+6.38%-13.98%+29.62% 43.95B
-6.39%-5.64%+17.29%-6.64% 32.35B
Average +0.45%+2.52%-15.19%+11.71% 73.72B
Weighted average by Cap. +0.75%+3.03%-12.34%+20.82%

Financials

2026 *2027 *
Net sales 2.09M 1.86M 1.72M 1.56M 2.93M 197M 2.97M 20.59M 8.08M 103M 7.82M 7.66M 330M 8.94M 7.96M 7.37M 6.67M 12.55M 844M 12.73M 88.22M 34.62M 443M 33.52M 32.82M 1.41B
Net income -19.42M -17.3M -16.01M -14.51M -27.28M -1.83B -27.66M -192M -75.25M -964M -72.86M -71.34M -3.07B -22.87M -20.36M -18.85M -17.08M -32.12M -2.16B -32.57M -226M -88.59M -1.13B -85.77M -83.98M -3.62B
Net Debt - -
Projected Income Statement - Annual - Femasys Inc.
Logo Femasys Inc.
Femasys Inc. is a biomedical company. The Company is focused on addressing the unmet needs of women worldwide with a broad portfolio of in-office, accessible, and therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable blended biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. It also developed FemCerv, which is an endocervical tissue sampler for cervical cancer diagnosis; FemVue, which is a companion diagnostic for fallopian tube assessment; FemCath, which is an intrauterine catheter, and FemChec.
Employees
53
Date Price Change Volume
26-10-21 US$1.650 -1.20% 32,512
26-10-20 US$1.670 +2.45% 34,001
26-10-19 US$1.630 -1.21% 93,691
26-10-16 US$1.650 -4.90% 58,524
26-10-15 US$1.735 +11.22% 130,829
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Femasys Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.670USD
Average target price
14.33USD
Spread / Average Target
+758.28%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Femasys Inc.
  1. Stock Market
  2. Stocks
  3. FEMY Stock